Laneke LuiesMari van ReenenKatharina RonacherGerhard WalzlDu Toit Loots
Our findings show the capacity of metabolomics to predict treatment failure at the time of diagnosis, which potentially offers significant benefits for the use in new drug development clinical trials and individualized patient care.
Akeredolu Motolani DeborahAdeniji Oluwashola DavidAdeyemi Samuel OladeleAdelusi Bamidele Samuel
Akeredolu Motolani DeborahAdeniji Oluwashola DavidAdeyemi Samuel OladeleAdelusi Bamidele Samuel
A DeborahAdeniji Oluwashola DavidAdeyemi Samuel OladeleA. Samuel
Owais A. HussainKhurum Nazir Junejo
David HornéSarah RoyceMasahiro NaritaPayam NahidKaren R Steingart